Impact of Hepatitis C Virus Infection on Hepatocellular Carcinoma.
Publication/Presentation Date
12-1-2015
Abstract
Hepatitis C virus (HCV)-associated hepatocellular carcinoma (HCC) incidence in the United States is increasing, partly because of risk factors such as diabetes, fatty liver, hepatitis B virus, and human immunodeficiency virus coinfection. Achieving sustained virologic response (SVR) is the most significant factor in reducing HCV-associated HCC incidence. Improved SVR with the next generation of direct-acting antivirals brings hope for decreased HCC mortality. Nevertheless, surveillance for HCC remains important because HCC can still occur despite SVR, especially in cirrhotics. Individualized risk stratification through increased understanding of HCC pathogenesis and improved surveillance holds the promise for future reduction of HCC incidence.
Volume
44
Issue
4
First Page
761
Last Page
773
ISSN
1558-1942
Published In/Presented At
Tholey, D. M., & Ahn, J. (2015). Impact of Hepatitis C Virus Infection on Hepatocellular Carcinoma. Gastroenterology clinics of North America, 44(4), 761–773. https://doi.org/10.1016/j.gtc.2015.07.005
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
26600218
Department(s)
Administration and Leadership
Document Type
Article